Author:
Fischer Bradford D.,Licata Stephanie C.,Edwankar Rahul V.,Wang Zhi-Jian,Huang Shengming,He Xiaohui,Yu Jianming,Zhou Hao,Johnson Edward M.,Cook James M.,Furtmüller Roman,Ramerstorfer Joachim,Sieghart Werner,Roth Bryan L.,Majumder Samarpan,Rowlett James K.
Subject
Cellular and Molecular Neuroscience,Pharmacology
Reference27 articles.
1. TPA023 [7-(1,1-Dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-30ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine], an agonist selective for α2 and α3-containing GABAA receptors, is a nonsedating anxiolytic in rodents and primates;Atack;J. Pharmacol. Exp. Ther.,2006
2. Identification of receptor domains that modify ligand binding to 5-hydroxytryptamine2 and 5-hydroxytryptamine1c serotonin receptors;Choudhary;Mol. Pharmacol.,1992
3. Enhanced learning and memory and altered GABAergic synaptic transmission in mice lacking the alpha 5 subunit of the GABAA receptor;Collinson;J. Neurosci.,2002
4. Effects of behaviorally active drugs in a conflict-punishment procedure in rats;Cook,1973
5. Cook, J.M., Zhou, H., Huang, S., Srirama Sarma, P.V.V., Zhang, C., 2009. Stereospecific anxiolytic and anticonvulsant agents with reduced muscle-relaxant, sedative-hypnotic and ataxic effects, US Patent 7,618,958 B2, Issued November 17, 2009.
Cited by
54 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献